Mechanism and Regulation of Nonhomologous DNA End Joining
非同源DNA末端连接的机制和调控
基本信息
- 批准号:7942230
- 负责人:
- 金额:$ 15.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-08-01 至 2015-01-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAgeAgingBRCT DomainBindingCancer EtiologyCellsChemicalsChromosomal translocationChromosome PairingComplexDNADNA DamageDNA Double Strand BreakDNA RepairDNA Repair PathwayDNA SequenceDNA StructureDNA ligase IVDNA-PKcsDNA-Protein InteractionDevelopmentEnzymesFree RadicalsHistonesHumanIonizing radiationKu ProteinLengthLigaseLigationMalignant NeoplasmsMediatingModificationMutationNonhomologous DNA End JoiningPathway interactionsPolymerasePositioning AttributePriceProcessPropertyProteinsRadiationRadiation-Sensitizing AgentsRegulationSiteSomatic CellSystemTailTestingTherapeuticTimeVariantVertebral columnVertebratesWorkX-Ray Crystallographyartemischemotherapyflexibilityhomologous recombinationimprovedin vivoinhibitor/antagonistinorganic phosphateinsightmutantnucleasephosphodiesterpublic health relevancereconstitutionrepairedsmall moleculespatial relationshipstoichiometry
项目摘要
DESCRIPTION (provided by applicant): Double-strand DNA breaks (DSBs) occur in all cells multiple times per day. Homologous recombination (HR) and nonhomologous DNA end-joining (NHEJ) are the two primary pathways for repairing DSBs. However, NHEJ is the more general pathway because it does not require a homologous donor, and NHEJ is sufficiently flexible that it can join almost any pair of incompatible DNA ends. The flexibility of NHEJ is essential because natural causes of DSBs (ionizing radiation, free radicals, enzyme malfunction) generate DNA ends with diverse chemical and structural configurations. Hence, that flexibility is well-suited for the task, but the price that we pay for that flexibility is that NHEJ causes DNA sequence changes at most sites where it functions (in humans and other vertebrates). Hence, NHEJ generates somatic cell mutations that cause cancer and likely contribute to aging. The flexibility of NHEJ represents one of the most sophisticated protein:DNA interaction pathways. Though we know most of the proteins that participate in NHEJ and know, in broad terms, what they do, we do not have a clear picture of how they function together, their spatial configuration, or the temporal relationships. With a clearer mechanistic and structural picture of human NHEJ, we will be in a position to develop small molecule inhibitors that may be useful for treating cancer (as chemotherapy or as a radiation sensitizer). Aims 1 and 2 of this proposal focus precisely on the issues of structural and spatial relationships among the NHEJ proteins and with the DNA ends. Aim 3 tests the hypothesis that the NHEJ ligase complex is important for making key end-to-end contacts during NHEJ. Aim 4 describes development of a more robust NHEJ reconstitution. In Aim 4, that system is then used to identify any remaining NHEJ factors by testing for enhancement of activity. Aim 5 describes analysis of how histone octamers influence the nuclease, polymerase, and ligase activities of NHEJ. These studies will markedly improve our understanding of how NHEJ participates in processes such as chromosomal translocations that are of key importance in cancer etiology and how NHEJ might be made 'druggable' for therapeutic purposes.
PUBLIC HEALTH RELEVANCE: This project would clarify our insights into one of the key pathways for the repair of DNA damage. These insights will allow us to understand how some of the DNA damage that causes cancer and aging occurs. The benefits of some chemotherapy and therapeutic radiation work can be increased by this deeper level of understanding of this key DNA repair pathway.
描述(由申请方提供):所有细胞每天多次发生双链DNA断裂(DSB)。同源重组(HR)和非同源DNA末端连接(NHEJ)是DSB修复的两条主要途径。然而,NHEJ是更通用的途径,因为它不需要同源供体,并且NHEJ足够灵活,可以连接几乎任何一对不相容的DNA末端。NHEJ的灵活性是必不可少的,因为DSB的自然原因(电离辐射,自由基,酶故障)产生具有不同化学和结构构型的DNA末端。因此,这种灵活性非常适合这项任务,但我们为这种灵活性付出的代价是NHEJ在其发挥作用的大多数位点(在人类和其他脊椎动物中)引起DNA序列的变化。因此,NHEJ产生导致癌症的体细胞突变,并可能导致衰老。NHEJ的灵活性代表了最复杂的蛋白质:DNA相互作用途径之一。虽然我们知道大多数参与NHEJ的蛋白质,并且从广义上知道它们的作用,但我们并不清楚它们如何共同发挥作用,它们的空间结构或时间关系。随着人类NHEJ的更清晰的机制和结构图片,我们将能够开发可能用于治疗癌症的小分子抑制剂(作为化疗或放射增敏剂)。本提案的目的1和2精确地集中在NHEJ蛋白质之间以及与DNA末端的结构和空间关系的问题上。目的3测试NHEJ连接酶复合物对于在NHEJ期间进行关键的端对端接触是重要的假设。目的4描述了更稳健的NHEJ重构的开发。在目标4中,该系统然后用于通过测试活性的增强来识别任何剩余的NHEJ因子。目的5分析组蛋白八聚体如何影响NHEJ的核酸酶、聚合酶和连接酶活性。这些研究将显著提高我们对NHEJ如何参与癌症病因学中至关重要的染色体易位等过程以及NHEJ如何出于治疗目的而“可药用”的理解。
公共卫生相关性:该项目将阐明我们对DNA损伤修复的关键途径之一的见解。这些见解将使我们了解导致癌症和衰老的一些DNA损伤是如何发生的。一些化疗和放射治疗工作的好处可以通过对这一关键DNA修复途径的更深层次的理解来增加。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL R LIEBER其他文献
MICHAEL R LIEBER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL R LIEBER', 18)}}的其他基金
Mechanisms of Human Lymphoid Chromosomal Translocation
人类淋巴染色体易位的机制
- 批准号:
10219165 - 财政年份:2016
- 资助金额:
$ 15.79万 - 项目类别:
Mechanisms of Human Lymphoid Chromosomal Translocation
人类淋巴染色体易位的机制
- 批准号:
9756315 - 财政年份:2016
- 资助金额:
$ 15.79万 - 项目类别:
Mechanisms of Human Lymphoid Chromosomal Translocation
人类淋巴染色体易位的机制
- 批准号:
9099617 - 财政年份:2016
- 资助金额:
$ 15.79万 - 项目类别:
Site-Specific Recombination in Human Health & Disease
人类健康中的位点特异性重组
- 批准号:
10400938 - 财政年份:2016
- 资助金额:
$ 15.79万 - 项目类别:
Site-Specific Recombination in Human Health & Disease
人类健康中的位点特异性重组
- 批准号:
10162067 - 财政年份:2016
- 资助金额:
$ 15.79万 - 项目类别:
Site-Specific Recombination in Human Health & Disease
人类健康中的位点特异性重组
- 批准号:
10618161 - 财政年份:2016
- 资助金额:
$ 15.79万 - 项目类别:
Selective Inhibitors of the Artemis Endonuclease
Artemis 核酸内切酶的选择性抑制剂
- 批准号:
8420339 - 财政年份:2012
- 资助金额:
$ 15.79万 - 项目类别:
Selective Inhibitors of the Artemis Endonuclease
Artemis 核酸内切酶的选择性抑制剂
- 批准号:
8261909 - 财政年份:2012
- 资助金额:
$ 15.79万 - 项目类别:
Mechanism and Regulation of Nonhomologous DNA End Joining
非同源DNA末端连接的机制和调控
- 批准号:
8894424 - 财政年份:2003
- 资助金额:
$ 15.79万 - 项目类别:
MECHANISM AND REGULATION OF NONHOMOLOGOUS DNA ENDJOINING
DNA非同源连接的机制和调控
- 批准号:
6596588 - 财政年份:2003
- 资助金额:
$ 15.79万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
- 批准号:
23K07844 - 财政年份:2023
- 资助金额:
$ 15.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of Age-dependent Functional Changes in Skeletal Muscle CB1 Receptors by an in Vitro Model of Aging-related Muscle Atrophy
通过衰老相关性肌肉萎缩的体外模型分析骨骼肌 CB1 受体的年龄依赖性功能变化
- 批准号:
22KJ2960 - 财政年份:2023
- 资助金额:
$ 15.79万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Joint U.S.-Japan Measures for Aging and Dementia Derived from the Prevention of Age-Related and Noise-induced Hearing Loss
美日针对预防与年龄相关和噪声引起的听力损失而导致的老龄化和痴呆症联合措施
- 批准号:
23KK0156 - 财政年份:2023
- 资助金额:
$ 15.79万 - 项目类别:
Fund for the Promotion of Joint International Research (International Collaborative Research)
The Effects of Muscle Fatigability on Gait Instability in Aging and Age-Related Falls Risk
肌肉疲劳对衰老步态不稳定性和年龄相关跌倒风险的影响
- 批准号:
10677409 - 财政年份:2023
- 资助金额:
$ 15.79万 - 项目类别:
Characterizing gut physiology by age, frailty, and sex: assessing the role of the aging gut in "inflamm-aging"
按年龄、虚弱和性别表征肠道生理学特征:评估衰老肠道在“炎症衰老”中的作用
- 批准号:
497927 - 财政年份:2023
- 资助金额:
$ 15.79万 - 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
- 批准号:
10679287 - 财政年份:2023
- 资助金额:
$ 15.79万 - 项目类别:
Role of AGE/RAGEsignaling as a driver of pathological aging in the brain
AGE/RAGE信号传导作为大脑病理性衰老驱动因素的作用
- 批准号:
10836835 - 财政年份:2023
- 资助金额:
$ 15.79万 - 项目类别:
Elucidation of the protein kinase NLK-mediated aging mechanisms and treatment of age-related diseases
阐明蛋白激酶NLK介导的衰老机制及年龄相关疾病的治疗
- 批准号:
23K06378 - 财政年份:2023
- 资助金额:
$ 15.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Underlying mechanisms of age-related changes in ingestive behaviors: From the perspective of the aging brain and deterioration of the gustatory system.
与年龄相关的摄入行为变化的潜在机制:从大脑老化和味觉系统退化的角度来看。
- 批准号:
23K10845 - 财政年份:2023
- 资助金额:
$ 15.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
通过 CCL2/11 靶向年龄激活的促炎趋化因子信号传导以增强衰老过程中的骨骼肌再生
- 批准号:
478877 - 财政年份:2023
- 资助金额:
$ 15.79万 - 项目类别:
Operating Grants